Hypericin and its Derivatives Act as Radiosensitizing Agents That Can Inhibit Tumor Initiating Cell Viability

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 119-127

Bentham Science Publishers

Access to resources Recommend Favorite

Manipulation of Dendritic Cells for Tumor Immunity

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 2, 2007-05 ,pp. : 151-160

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cells in Tumor Immunology and Immunotherapy

By  

Current Drug Targets, Vol. 5, Iss. 1, 2004-01 ,pp. : 17-39

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists

By  

Current Molecular Pharmacology, Vol. 11, Iss. 2, 2018-04 ,pp. : 113-121

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept

By  

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 56-71

Bentham Science Publishers

Access to resources Recommend Favorite